ENGN
NASDAQ · Biotechnology
Engene Holdings Inc
$7.21
-0.01 (-0.07%)
Analyst Consensus
Strong Buy
18
Analysts
High
Coverage
Price Target
Analyst Price Target
+806.1% upside
Low Target
$48.23
Average Target
$65.33
High Target
$96.03
Current Price
$7.21
Current
$7.21
$7.21
Target
$65.33
$65.33
$48.23
$65.33 avg
$96.03
Scenario Analysis
Bear Case
$48.23
568.9%
Low target
Base Case
$65.33
+806.1%
Avg target
Bull Case
$96.03
+1,231.9%
High target
Risk/Reward
2.2x
Favorable
Price in Context
52-Week High
$12.25
-41.1% from high
52-Week Low
$2.65
+172.1% from low
Target vs 52W High
$65.33
+433.3% vs high
Peer Consensus — Biotechnology
| Stock | Consensus | Analysts | Buy % | Target | Upside |
|---|---|---|---|---|---|
| ABBV | Buy | 39 | 69% | $257.58 | +24.3% |
| AMGN | Hold | 42 | 50% | $190.87 | -46.1% |
| GILD | Strong Buy | 37 | 81% | $362.68 | +162.3% |
| VRTX | Strong Buy | 39 | 79% | $438.34 | -3.7% |
| REGN | Strong Buy | 36 | 75% | $76.80 | -89.8% |
| ALNY | Strong Buy | 36 | 78% | $102.31 | -68.9% |
| INSM | Strong Buy | 26 | 92% | $143.40 | -3.3% |
| NTRA | Strong Buy | 27 | 89% | $142.91 | -27.6% |